Coming from Siemens, a new computerized system for breast biopsies in prone position is touted to provide better access to lesions:
Siemens Medical Solutions recently began introducing its new MammoTest biopsy table for biopsies in the prone position during breast cancer screening. Together with the syngo Opdima biopsy unit, where the patient is in a sitting position, Siemens offers now a comprehensive biopsy portfolio with MammoTest. This provides the physician with the choice of two stereotactic systems. The ergonomically designed table ensures examinations as comfortable as possible for the patient.
Siemens acquired the rights to the MammoTest system last summer from Fischer Imaging. The technology enables 360 degree access to lesions. In addition, biopsies can be performed more accurately using Polar Coordinate Targeting and a high resolution CCD (charged coupled device) camera. This improves workflow while reducing the examination time.
Syngo Opdima is already the gold standard of digital biopsy and detailed imaging. It is designed for fast, efficient needle and core biopsies and for localization. With a detector resolution of 20 Lp/mm (line pairs per millimeter), syngo Opdima exceeds all comparable systems. The system is compatible with most of the mammography products of the Siemens Mammomat range, including the Mammomat Novation digital full field system.
Siemens acquired the rights to the MammoTest system last summer from Fischer Imaging. The technology enables 360 degree access to lesions. In addition, biopsies can be performed more accurately using Polar Coordinate Targeting and a high resolution CCD (charged coupled device) camera. This improves workflow while reducing the examination time.